Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alkermes plc. Director's Dealing 2011

Sep 20, 2011

31048_dirs_2011-09-20_ee690a82-6469-4739-88dc-8e467143bdbd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2011-09-16

Reporting Person: LANDINE MICHAEL J (SVP, Corp Dev., Alkermes, Inc.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-09-16 Common Stock A 149227 Acquired 149227 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-09-16 Non Qualified Stock Option (Right to Buy) $19.40 A 15465 Acquired 2011-10-02 Common Stock (15465) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $19.40 A 29380 Acquired 2011-10-02 Common Stock (29380) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $19.40 A 5155 Acquired 2011-10-02 Common Stock (5155) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $4.77 A 18746 Acquired 2012-07-18 Common Stock (18746) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $4.77 A 6254 Acquired 2012-07-18 Common Stock (6254) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $7.36 A 9536 Acquired 2012-12-12 Common Stock (9536) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $7.36 A 65464 Acquired 2012-12-12 Common Stock (65464) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $9.97 A 26250 Acquired 2013-04-25 Common Stock (26250) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $9.97 A 8750 Acquired 2013-04-25 Common Stock (8750) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.57 A 875 Acquired 2013-10-17 Common Stock (875) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.57 A 30625 Acquired 2013-10-17 Common Stock (30625) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.16 A 23499 Acquired 2013-12-10 Common Stock (23499) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $12.16 A 1 Acquired 2013-12-10 Common Stock (1) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $12.30 A 6750 Acquired 2014-07-12 Common Stock (6750) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $12.30 A 20250 Acquired 2014-07-12 Common Stock (20250) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.90 A 61861 Acquired 2014-12-17 Common Stock (61861) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.90 A 1139 Acquired 2014-12-17 Common Stock (1139) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $18.60 A 28374 Acquired 2015-12-09 Common Stock (28374) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $18.60 A 5376 Acquired 2015-12-09 Common Stock (5376) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $20.79 A 4218 Acquired 2016-05-02 Common Stock (4218) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $20.79 A 12657 Acquired 2016-05-02 Common Stock (12657) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $14.38 A 29145 Acquired 2016-12-12 Common Stock (29145) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $14.38 A 855 Acquired 2016-12-12 Common Stock (855) Direct
2011-09-16 Incentive Stock Option (Right to Buy) $15.95 A 5000 Acquired 2017-06-01 Common Stock (5000) Direct
2011-09-16 Non Qualified Stock Option (Right to Buy) $15.95 A 15000 Acquired 2017-06-01 Common Stock (15000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $14.13 A 15000 Acquired 2017-11-05 Common Stock (15000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $12.29 A 40000 Acquired 2018-05-27 Common Stock (40000) Direct
2011-09-16 Employee Stock Option (Right to Buy) $8.55 A 65000 Acquired 2019-05-26 Common Stock (65000) Direct
2011-09-16 Restricted Stock Award $0 A 4250 Acquired Common Stock (4250) Direct

Footnotes

F1: Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.

F2: These options are fully vested in accordance with their terms.

F3: Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.

F4: 75% vested as of 9/16/11, remainder vests on 11/5/11.

F5: 75% vested as of 9/16/11, remainder vests on 5/27/12.

F6: 50% vested as of 9/16/11, remainder vests in 2 equal annual installments beginning on 5/26/12.

F7: Received in exchange for, and having substantially the same terms as, restricted stock unit awards of Alkermes, Inc. common stock in connection with the Merger.